Clinical implications of incidental venous thromboembolism in cancer patients.
Frits I MulderMarcello Di NisioCihan AyMarc CarrierFloris T M BoschAnnelise SegersNoémie KraaijpoelMichael A GrossoGeorge ZhangPeter VerhammeTzu-Fei WangJeffrey I WeitzSaskia MiddeldorpGary RaskobLudo F M BeenenHarry R BüllerNick van EsPublished in: The European respiratory journal (2020)
Clinical adverse outcomes are substantial in both cancer patients with incidental and symptomatic VTE, supporting current guideline recommendations that suggest treating incidental VTE in the same manner as symptomatic VTE.